NDAINTRAVENOUSSOLUTION
Approved
Oct 2025
Lifecycle
Growth
Competitive Pressure
30/100
Data completeness
2/8 — Basic
DEHYDRATED ALCOHOL (dehydrated alcohol) by Be Pharms is intra-arterial catheter into a target septal vessel, which causes the hypertrophied septum to thin. First approved in 2025.
Drug data last refreshed 2h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Dehydrated Alcohol is an intravenous solution administered via intra-arterial catheter injection into target septal vessels, causing hypertrophied septal tissue to thin. The product is indicated for conditions involving septal hypertrophy, delivered through a specialized catheterization procedure. This represents a novel ablative approach to structural cardiac or similar conditions requiring targeted tissue reduction.
Launch6.0 years to LOE
Recent launch stage with moderate competitive pressure (30) creates opportunities for market development, launch team growth, and field force expansion.
Mechanism of Action
intra-arterial catheter into a target septal vessel, which causes the hypertrophied septum to thin.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Current job market shows no directly linked positions, likely reflecting early-stage launch status and small Be Pharms commercial footprint. Career opportunities will emerge as market penetration increases, particularly in specialized sales, procedural training, and payer management roles.
Brand ManagerField Sales Representative
Worked on DEHYDRATED ALCOHOL at Be Pharms? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.